ImStem Biotechnology
PrivateLast Round
Pre Seed
Aug 23, 2013
Total Funding Raised
$1.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ImStem Biotechnology is a biopharmaceutical company that develops human embryonic stem cell-derived mesenchymal stem cell therapies for the treatment of autoimmune, degenerative, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImStem Biotechnology Comparables
Compare ImStem Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ernexa Therapeutics Inc. | 78% | |
| Brainstorm Cell Therapeutics Inc. | 77% | |
| AgeX Therapeutics | 76% | |
ImStem Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 23, 2013 | ||||
| Grant | Jun 11, 2013 |
Key People
Founding team and executive leadership
ImStem Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1420% MoM.
- Jan 19, 2026
Monthly visitors grew 107% MoM.
ImStem Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImStem Biotechnology's valuation, stock price, and market status.